Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: Overview and methodological considerations

European Heart Journal - Cardiovascular Pharmacotherapy

Volumn 1, Issue 4, 2015, Pages 232-244

  Jukema, J Wouter ^a   Lettino, Maddalena ^b   Widimský, Petr ^c   Danchin, Nicolas ^d   Bardaji, Alfredo ^e   Barrabes, Jose A ^f   Cequier, Angel ^g   Claeys, Marc J ^h   Luca, Leonardo De ⁱ   Dörler, Jakob ^j   Erlinge, David ^k   Erne, Paul ^l   Goldstein, Patrick ^m   Koul, Sasha M ^k   Lemesle, Gilles ^m   Lüscher, Thomas F ⁿ   Matter, Christian M ⁿ   Montalescot, Gilles ^o   Radovanovic, Dragana ^l   Lopez Sendón, Jose ^p   Tousek, Petr ^c   Weidinger, Franz ^q   Weston, Clive F M ^r   Zaman, Azfar ^s   Zeymer, Uwe ^t   more..

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c CHARLES UNIVERSITY   (Czech Republic)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h ANTWERP UNIVERSITY HOSPITAL   (Belgium)

ⁱ EUROPEAN HOSPITAL   (Italy)

^j INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^k LUND UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITY OF ZURICH   (Switzerland)

^m LILLE UNIVERSITY HOSPITAL   (France)

ⁿ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^o PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^p HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^q Hospital Rudolfstiftung   (Austria)

^r SWANSEA UNIVERSITY   (United Kingdom)

^s NEWCASTLE UNIVERSITY   (United Kingdom)

^t IHF Institut für Herzinfarktforschung   (Germany)

more..

Author keywords

Acute coronary syndrome; Antithrombotics; Clopidogrel; Methodology; Non st segment myocardial infarction; Observational; P2y12 inhibitors; Prasugrel; Real world evidence; Registries; St segment elevation myocardial infarction; Ticagrelor

Indexed keywords

CLOPIDOGREL; PRASUGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR ANTAGONIST; TICAGRELOR; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; COMPARATIVE STUDY; DRUG EFFICACY; DRUG SAFETY; DUAL ANTIPLATELET THERAPY; EUROPE; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; REVIEW; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; EUROPE; HUMANS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; REGISTRIES;

EID: 84988859112     PISSN: 20556837     EISSN: 20556845     Source Type: Journal    
DOI: 10.1093/ehjcvp/pvv024     Document Type: Review

References (84)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER III, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation 2015;131:e29-e322.
2. World Health Organization. The top 10 causes of death. Fact sheet N8 310. Updated May 2014. Internet: http://www.who.int/mediacentre/factsheets/fs310/en/(12 March 2015).
3. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-2567.
4. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, WijnsW, Zahger D, Bax JJ, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Achenbach S, Badimon L, Bertrand M, Botker HE, Collet JP, Crea F, Danchin N, Falk E, Goudevenos J, Gulba D, Hambrecht R, Herrmann J, Kastrati A, Kjeldsen K, Kristensen SD, Lancellotti P, Mehilli J, Merkely B, Montalescot G, Neumann FJ, Neyses L, Perk J, Roffi M, Romeo F, Ruda M, Swahn E, Valgimigli M, Vrints CJ, Widimsky P. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32: 2999-3054.
5. Steg P, James S, Atar D, Badano L, Blomstrom-Lundqvist C, Borger M, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick A, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey K, Valgimigli M, van't Hof A, Widimsky P, Zahger D. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
6. Krumholz HM, Wang Y, Chen J, Drye EE, Spertus JA, Ross JS, Curtis JP, Nallamothu BK, Lichtman JH, Havranek EP, Masoudi FA, Radford MJ, Han LF, Rapp MT, Straube BM, Normand SL. Reduction in acute myocardial infarction mortality in the United States: Risk-standardized mortality rates from 1995-2006. JAMA 2009;302:767-773.
7. Curry LA, Spatz E, Cherlin E, Thompson JW, Berg D, Ting HH, Decker C, Krumholz HM, Bradley EH. What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? A qualitative study. Ann Intern Med 2011; 154:384-390.
8. Agency for Healthcare Research and Quality (AHRQ). In Gliklich RE, Dreyer NA, eds. Registries for evaluating patient outcomes: A user's guide. 2nd ed. Rockville, MD, USA: AHRQ Publication No. 10-EHC049. http://www.ncbi.nlm.nih.gov/books/NBK49444/(12 March 2015).
9. European Epidemiology Federation. Good Epidemiological Practice (GEP): Proper Conduct in Epidemiologic Research. http://ieaweb.org/2010/04/good-epidemiological-practice-gep/(22 October 2014).
10. European Medicines Agency. European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP): ENCePP Guide on Methodological Standards in Pharmacoepidemiology (Revision 1, 13 June 2012). http://www.encepp.eu/standards-And-guidances/documents/ENCePPGuideofMethStandardsinPE-2.pdf (26 June 2012).
11. Cannon P. Statement on matching language to the type of evidence used in describing observational studies vs. randomized trials. Eur Heart J 2013;34:20-21.
12. Alpert JS. Are data from clinical registries of any value? Eur Heart J 2000;21: 1399-1401.
13. European Society of Cardiology. EURObservational Research Programme. http://www.escardio.org/guidelines-surveys/eorp/Pages/welcome.aspx(12 March 2015).
14. Gitt AK, Bueno H, Danchin N, Fox K, Hochadel M, Kearney P, Maggioni AP, Opolski G, Seabra-Gomes R, Weidinger F. The role of cardiac registries in evidence-based medicine. Eur Heart J 2010;31:525-529.
15. Dorler J, Alber HF, Altenberger J, Bonner G, Benzer W, Grimm G, Huber K, Kaltenbach L, Pfeiffer KP, Schuchlenz H, Siostrzonek P, Zenker G, Pachinger O, Weidinger F. Primary percutaneous intervention of ST-elevation myocardial infarction in Austria: Results from the Austrian acute PCI registry 2005-2007. Wien Klin Wochenschr 2010;122:220-228.
16. Suessenbacher A, Doerler J, Alber H, Aichinger J, Altenberger J, Benzer W, Christ G, Globits S, Huber K, Karnik R, Norman G, Siostrzonek P, Zenker G, Pachinger O, Weidinger F. Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registry. EuroIntervention 2008;4:271-276.
17. Dorler J, Edlinger M, Alber HF, Altenberger J, BenzerW, Grimm G, Huber K, Pachinger O, Schuchlenz H, Siostrzonek P, Zenker G, Weidinger F. Clopidogrel pre-Treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Eur Heart J 2011;32:2954-2961.
18. Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus KL. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI). Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J 2004;25:322-328.
19. Zeymer U, Hochadel M, Hauptmann KE, Wiegand K, Schuhmacher B, Brachmann J, Gitt A, Zahn R. Intra-Aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the ALKK-PCI registry. Clin Res Cardiol 2013;102:223-227.
20. Zeymer U, Hochadel M, Thiele H, Andresen D, Schuhlen H, Brachmann J, Elsasser A, Gitt A, Zahn R. Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the ALKK-PCI registry. EuroIntervention 2014; doi: 10.4244/EIJY14M08-04.
21. Harle T, Zeymer U, Schwarz AK, Luers C, Hochadel M, Darius H, Kasper W, Hauptmann KE, Andresen D, Elsasser A. Use of drug-eluting stents in acute myocardial infarction with persistent ST-segment elevation: Results of the ALKK PCI-registry. Clin Res Cardiol 2014;103:373-380.
22. Zeymer U, Hochadel M, Gitt A, Zahn R. Comparative efficacy and safety of prasugrel and clopidogrel in patientsWith STEMI undergoing primary PCI in the prasugrel core population in clinical practice. Results of the Prospective ALKK-registry (abstract). Presentation at American Heart Association AHA Scientific Sessions November 15-19, 2014; Chicago, Illinois, USA. Circulation 2014;130(Suppl 2):A20089.
23. Zeymer U, Hochadel M, Lauer B, Kaul N, Wohrle J, Andresen D, Schwimmbeck P, Solzbach U, ThieleH, Gitt A, Diller F, Zahn R. Use, efficacy and safety of prasugrel in patients with ST segment elevation myocardial infarction scheduled for primary percutaneous coronary intervention in clinical practice. Results of the prospective ATACS-registry. Int J Cardiol 2015;184C:122-127.
24. Zeymer U, Gitt A, Hochadel M, Lauer B, Kaul N, Andresen D, Zahn R. Pretreatment with prasugrel is safe and associated with an improvement outcome in patients with NSTE-ACS (abstract P4866). Eur Heart J 2013;34(Suppl):887.
25. Radovanovic D, Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart 2010;96:917-921.
26. Kurz DJ, Radovanovic D, Seifert B, Bernheim AM, Roffi M, Pedrazzini G, Windecker S, Erne P, Eberli FR. Comparison of prasugrel and clopidogrel-Treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry. Eur Heart J Acute Cardiovasc Care 2015. [Epub ahead of print].
27. Jeger R, Jaguszewski M, Nallamothu BN, Luscher TF, Urban P, Pedrazzini GB, Erne P, Radovanovic D. Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: A nationwide study cohort from the AMIS Plus registry. Int J Cardiol 2014;172:76-81.
28. Radovanovic D, Nallamothu BK, Seifert B, Bertel O, Eberli F, Urban P, Pedrazzini G, Rickli H, Stauffer JC, Windecker S, Erne P. Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011. Eur Heart J Acute Cardiovasc Care 2012;1:183-191.
29. Erne P, Gutzwiller F, Urban P, Maggiorini M, Keller PF, Radovanovic D. Characteristics and outcome in acute coronary syndrome patients with and without established modifiable cardiovascular risk factors: insights from the Nationwide AMIS Plus Registry 1997-2010. Cardiology 2012;121:228-236.
30. Kurz DJ, Bernstein A, Hunt K, Radovanovic D, Erne P, Siudak Z, Bertel O. Simple point-of-care risk stratification in acute coronary syndromes: The AMIS model. Heart 2009;95:662-668.
31. Claeys MJ, de Meester A, Convens C, Dubois P, Boland J, De Raedt H, Vranckx P, Coussement P, Gevaert S, Sinnaeve P, Evrard P, Beauloye C, Renard M, Vrints C. Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction. Arch Intern Med 2011;171:544-549.
32. Claeys MJ, Sinnaeve PR, Convens C, Dubois P, Boland J, Vranckx P, Gevaert S, de Meester A, Coussement P, De Raedt H, Beauloye C, Renard M, Vrints C, Evrard P. STEMI mortality in community hospitals versus PCI-capable hospitals: Results from a nationwide STEMI network programme. Eur Heart J Acute Cardiovasc Care 2012;1: 40-47.
33. Gevaert SA, De Bacquer D, Evrard P, Convens C, Dubois P, Boland J, Renard M, Beauloye C, Coussement P, De Raedt H, de Meester A, Vandecasteele E, Vranckx P, Sinnaeve PR, Claeys MJ. Gender, TIMI risk score and in-hospital mortality in STEMI patients undergoing primary PCI: Results from the Belgian STEMI registry. EuroIntervention 2014;9:1095-1101.
34. Gevaert SA, De Bacquer D, Evrard P, Renard M, Beauloye C, Coussement P, De Raedt H, Sinnaeve PR, Claeys MJ. Renal dysfunction in STEMI-patients undergoing primary angioplasty: higher prevalence but equal prognostic impact in female patients: An observational cohort study from the Belgian STEMI registry. BMC Nephrol 2013;14:62.
35. Vandecasteele EH, De Buyzere M, Gevaert S, de Meester A, Convens C, Dubois P, Boland J, Sinnaeve P, De Raedt H, Vranckx P, Coussement P, Evrard P, Beauloye C, Renard M, Claeys MJ. Reperfusion therapy and mortality in octogenarian STEMI patients: Results from the Belgian STEMI registry. Clin Res Cardiol 2013;102:837-845.
36. Claeys MJ, Sinnaeve PR, Convens C, Dubois P, Boland J, Vranckx P, Gevaert S, Coussement P, Beauloye C, Renard M, Vrints C, Evrard P. Inter-hospital variation in length of hospital stay after ST-elevation myocardial infarction: Results from the Belgian STEMI registry. Acta Cardiol 2013;68:235-239.
37. Olivari Z, Steffenino G, Savonitto S, Chiarella F, Chinaglia A, Lucci D, Maggioni AP, Pirelli S, Scherillo M, Scorcu G, Tricoci P, Urbinati S. The management of acute myocardial infarction in the cardiological intensive care units in Italy: The 'BLITZ 4 Qualita' campaign for performance measurement and quality improvement. Eur Heart J Acute Cardiovasc Care 2012;1:143-152.
38. Urbinati S, Olivari Z, Gonzini L, Savonitto S, Farina R, Del Pinto M, Valbusa A, Fantini G, Mazzoni A, Maggioni AP. Secondary prevention after acute myocardial infarction: Drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry. Eur J Prev Cardiol 2014. [Epub ahead of print].
39. Zeymer U, Giannitsis E, Senges J. Long-Term efficacy and safety of prasugrel compared to clopidogrel in patients with acute coronary syndromes in clinical practice. Results of the prospective German CPU registry (abstract: P6469). Eur Heart J 2014;35(Suppl):1161-1162.
40. Tousek P, Tousek F, Horak D, Cervinka P, Rokyta R, Pesl L, Jarkovsky J, Widimsky P. The incidence and outcomes of acute coronary syndromes in a central European country: Results of the CZECH-2 registry. Int J Cardiol 2014;173:204-208.
41. Barrabes JA, Bardaji A, Jimenez-Candil J, Del Nogal Saez F, Bodi V, Basterra N, Marco E, Melgares R, Cunat de la Hoz J, Fernandez-Ortiz A. Prognosis and management of acute coronary syndrome in Spain in 2012: The DIOCLES study. Rev Esp Cardiol 2014. doi:10.1016/j.recesp.2014.03.010.
42. Bueno H, Danchin N, Tafalla M, Bernaud C, Annemans L, Van deWerf F. EPICOR (long-TErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: Rationale, design, and baseline characteristics. Am Heart J 2013;165:8-14.
43. Bueno H, Sinnaeve P, Annemans L, Danchin N, Licour M, Medina J, Pocock S, Sanchez-Covisa J, Storey RF, Jukema JW, Zeymer U, Van de Werf F. Opportunities for improvement in anti-Thrombotic therapy and other strategies for the management of acute coronary syndromes: insights fromEPICOR, an international study of current practice patterns. Eur Heart J Acute Cardiovasc Care 2015. [Epub ahead of print].
44. Pocock S, Bueno H, Licour M, Medina J, Zhang L, Annemans L, Danchin N, Huo Y, Van de Werf F. Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-TErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study. Eur Heart J Acute Cardiovasc Care 2014. [Epub ahead of print].
45. Sinnaeve PR, Zeymer U, Bueno H, Danchin N, Medina J, Sanchez-Covisa J, Licour M, Annemans L, Jukema JW, Pocock S, Storey RF, Van deWerf F. Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: findings from the EPICOR study. Eur Heart J Acute Cardiovasc Care 2015;4:254-262.
46. Zeymer U, Heuer H, Schwimmbeck P, Genth-Zotz S, Wolff K, Nienaber CA. Guideline-Adherent therapy in patients with acute coronary syndromes : The EPICOR registry in Germany. Herz 2015;40(Suppl 1):27-35.
47. De Luca L, Leonardi S, Cavallini C, Lucci D, Musumeci G, Caporale R, Abrignani MG, Lupi A, Rakar S, Gulizia MM, Bovenzi FM, De Servi S. Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT study. Eur Heart J Acute Cardiovasc Care 2014. [Epub ahead of print].
48. De Luca L, Leonardi S, Smecca IM, Formigli D, Lucci D, Gonzini L, Tuccillo B, Olivari Z, Gulizia MM, Bovenzi FM, De Servi S; on behalf of the EYESHOT Investigators. Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study. Eur Heart J Cardiovasc Pharmacother 2015;1:168-178.
49. De Luca L, Leonardi S, Tubaro M, Gonzini L, Lucci D, Trimarco B, Misuraca G, Ledda A, Gulizia MM, De Servi S. Is the use of risk scores an indicator of guideline adherence for patients with acute coronary syndromes? Insights from the EYESHOT Registry. Int J Cardiol 2015;187:80-83.
50. Danchin N, Coste P, Ferrieres J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Gueret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou JP, Simon T. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the French registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008;118:268-276.
51. Cambou JP, Simon T, Mulak G, Bataille V, Danchin N. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics. Arch Mal Coeur Vaiss 2007;100:524-534.
52. Danchin N, Puymirat E, Steg PG, Goldstein P, Schiele F, Belle L, Cottin Y, Fajadet J, Khalife K, Coste P, Ferrieres J, Simon T. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: The French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort. Circulation 2014;129:1629-1636.
53. Hanssen M, Cottin Y, Khalife K, Hammer L, Goldstein P, Puymirat E, Mulak G, Drouet E, Pace B, Schultz E, Bataille V, Ferrieres J, Simon T, Danchin N. French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010. Heart 2012;98:699-705.
54. Puymirat E, Aissaoui N, Cottin Y, Vanzetto G, Carrie D, Isaaz K, Valy Y, Tchetche D, Schiele F, Steg PG, Simon T, Danchin N. Effect of coronary thrombus aspiration during primary percutaneous coronary intervention on one-year survival (from the FAST-MI 2010 Registry). Am J Cardiol 2014;114:1651-1657.
55. Puymirat E, Aissaoui N, Coste P, Dentan G, Bataille V, Drouet E, Mulak G, Carrie D, Blanchard D, Simon T, Danchin N. Comparison of efficacy and safety of a standard versus a loading dose of clopidogrel for acute myocardial infarction in patients ≥ 75 years of age (from the FAST-MI registry). Am J Cardiol 2011;108:755-759.
56. Simon T, Steg PG, Gilard M, Blanchard D, Bonello L, Hanssen M, Lardoux H, Coste P, Lefevre T, Drouet E, Mulak G, Bataille V, Ferrieres J, Verstuyft C, Danchin N. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: Results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry. Circulation 2011; 123:474-482.
57. Lim P, Moutereau S, Simon T, Gallet R, Probst V, Ferrieres J, Gueret P, Danchin N. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]). Am J Cardiol 2013;111:31-37.
58. Puymirat E, Aissaoui N, Collet JP, Chaib A, Bonnet JL, Bataille V, Drouet E, Mulak G, Ferrieres J, Blanchard D, Simon T, Danchin N. Comparison of bleeding complications and one-year survival of low molecular weight heparin versus unfractioned heparin for acute myocardial infarction in elderly patients. The FAST-MI registry. Int J Cardiol 2013;166:106-110.
59. Andre R, Elbaz M, Simon T, Khalife K, Lim P, Ennezat PV, Coste P, Le Breton H, Bataille V, Ferrieres J, Danchin N. Prevalence, clinical profile and 3-year survival of acute myocardial infarction patients with and without obstructive coronary lesions: The FAST-MI 2005 registry. Int J Cardiol 2014;172:e247-e249.
60. Bougouin W, Marijon E, Puymirat E, Defaye P, Celermajer DS, Le Heuzey JY, Boveda S, Kacet S, Mabo P, Barnay C, Da Costa A, Deharo JC, Daubert JC, Ferrieres J, Simon T, Danchin N. Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: A 5-year cause-of-death analysis of the FAST-MI 2005 registry. Eur Heart J 2014;35:116-122.
61. Herrett E, Smeeth L, Walker L, Weston C. The Myocardial Ischaemia National Audit Project (MINAP). Heart 2010;96:1264-1267.
62. Simms A, Weston C, West R, Hall A, Batin P, Timmis A, Hemingway H, Fox K, Gale C. Mortality and missed opportunities along the pathway of care for ST-elevation myocardial infarction: A national cohort study. Eur Heart J Acute Cardiovasc Care 2015;4:241-253.
63. Zaman MJ, Stirling S, Shepstone L, Ryding A, Flather M, Bachmann M, Myint PK. The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: A cohort study of the Myocardial Ischaemia National Audit Project (MINAP). Eur Heart J 2014;35:1551-1558.
64. Gale CP, Cattle BA, Baxter PD, Greenwood DC, Simms AD, Deanfield J, Fox KA, Hall AS, West RM. Age-dependent inequalities in improvements in mortality occur early after acute myocardial infarction in 478, 242 patients in the Myocardial Ischaemia National Audit Project (MINAP) registry. Int J Cardiol 2013;168:881-887.
65. Weston C, Gavalova L, Whittaker T, van Leeven R. Myocardial Ischaemia National Audit Project. How the NHS cares for patients with heart attack. Annual Public Report April 2013-March 2014. http://www.ucl.ac.uk/nicor/audits/minap/publicreports (22 April 2015).
66. Clemmensen P, Grieco N, Ince H, Danchin N, Goedicke J, Ramos Y, Schmitt J, Goldstein P. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel-The European MULTIPRAC Registry. Eur Heart J Acute Cardiovasc Care 2015;4:220-229.
67. Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, Lagerqvist B, Lindahl B, Stenestrand U, Wallentin L. The SwedishWeb-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 2010;96:1617-1621.
68. SCAAR Annual Report 2011. Scand Cardiovasc J 2013;47(Suppl 62):55-76.
69. Damman P, Varenhorst C, Koul S, Eriksson P, Erlinge D, Lagerqvist B, James SK. Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]). Am J Cardiol 2014;113:64-69.
70. Schwalm T, Carlsson J, Meissner A, Lagerqvist B, James S. Current treatment and outcome of coronary in-stent restenosis in Sweden: A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention 2013; 9:564-572.
71. Fokkema ML, James SK, Albertsson P, Akerblom A, Calais F, Eriksson P, Jensen J, Nilsson T, de Smet BJ, Sjogren I, Thorvinger B, Lagerqvist B. Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). J Am Coll Cardiol 2013;61: 1222-1230.
72. Bondesson P, Lagerqvist B, James SK, Olivecrona GK, Venetsanos D, Harnek J. Comparison of two drug-eluting balloons: A report from the SCAAR registry. Euro- Intervention 2012;8:444-449.
73. Sarno G, Lagerqvist B, Carlsson J, Olivecrona G, Nilsson J, Calais F, Gotberg M, Nilsson T, Sjogren I, James S. Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Int J Cardiol 2013; 167:146-150.
74. Sarno G, Lagerqvist B, Frobert O, Nilsson J, Olivecrona G, Omerovic E, Saleh N, Venetzanos D, James S. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: A report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 2012;33:606-613.
75. Stenestrand U, James SK, Lindback J, Frobert O, Carlsson J, Schersten F, Nilsson T, Lagerqvist B. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-Term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 2010;31:177-186.
76. Matter C, Windecker S, Mach F, Rodondi N, Lüscher T. Swiss cooperative study acute coronary syndromes and inflammation. Cardiovasc Med 2011;14:167-168.
77. Klingenberg R, Heg D, Raber L, Carballo D, Nanchen D, Gencer B, Auer R, Jaguszewski M, Stahli BE, Jakob P, Templin C, Stefanini GG, Meier B, Vogt P, Roffi M, Maier W, Landmesser U, Rodondi N, Mach F, Windecker S, Juni P, Luscher TF, Matter CM. Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland. Heart 2015;101:854-863.
78. Auer R, Gencer B, Raber L, Klingenberg R, Carballo S, Carballo D, Nanchen D, Cornuz J, Vader JP, Vogt P, Juni P, Matter CM, Windecker S, Luscher TF, Mach F, Rodondi N. Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications. PLoS ONE 2014; 9:e93147.
79. Gencer B, Rodondi N, Auer R, Raber L, Klingenberg R, Nanchen D, Carballo D, Vogt P, Carballo S, Meyer P, Matter CM, Windecker S, Luscher TF, Mach F. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes. Eur J Intern Med 2015;26:56-62.
80. Gencer B, Auer R, Nanchen D, Raber L, Klingenberg R, Carballo D, Blum M, Vogt P, Carballo S, Meyer P, Matter CM, Windecker S, Luscher TF, Mach F, Rodondi N. Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes. Atherosclerosis 2015;239:118-124.
81. Raber L, Taniwaki M, Zaugg S, Kelbaek H, Roffi M, Holmvang L, Noble S, Pedrazzini G, Moschovitis A, Luscher TF, Matter CM, Serruys PW, Juni P, Garcia-Garcia HM, Windecker S. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): A serial intravascular ultrasonography study. Eur Heart J 2015;36:490-500.
82. Koshy A, Balasubramaniam K, Noman A, Zaman AG. Antiplatelet therapy in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A retrospective observational study of prasugrel and clopidogrel. Cardiovasc Ther 2014;32:1-6.
83. Delgado-Rodriguez M, Llorca J. Bias J., Epidemiol Commun Health 2004;58:635-641.
84. Neuman MD, Goldstein JN, Cirullo MA, Schwartz JS. Durability of class I American College of Cardiology/American Heart Association clinical practice guideline recommendations. JAMA 2014;311:2092-2100.